Sol-Gel Share Price
NASDAQ: SLGL | Healthcare$53.67
+$2.95 (5.82%) Last updated on 19 Nov, 2026 | 01:19 ISTSol-Gel Stock Performance
Sol-Gel Share Price Chart
$0.00$0.00
L
H
Sol-Gel Annual Profit & Loss
All figures in USD
Sol-Gel Balance Sheet
All figures in USD Million
Sol-Gel Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Sol-Gel
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Sol-Gel Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $66.62 | $50.72 | -26.02% |
Oct 2026 | $70.75 | $68.56 | -9.20% |
Sep 2026 | $70.42 | $75.50 | +2.22% |
Aug 2026 | $82.85 | $73.86 | -11.52% |
Jul 2026 | $72.81 | $83.48 | +10.06% |
Jun 2026 | $70.71 | $75.85 | -4.09% |
May 2026 | $75.31 | $79.08 | +15.88% |
Apr 2026 | $82.50 | $68.25 | -13.93% |
Mar 2026 | $89.64 | $79.30 | -11.89% |
Feb 2026 | $62.50 | $90.00 | +43.54% |
Jan 2026 | $43.65 | $62.70 | +49.96% |
Dec 2025 | $36.95 | $41.81 | +6.13% |